Radiation research favours Novoste, say analysts
This article was originally published in Clinica
Executive Summary
Despite concerns over the safety of intravascular radiation in certain patients and inconveniences associated with gamma-based systems, the technology should find acceptance in cardiac cath labs, according to investment firm Morgan Stanley Dean Witter.